Beta Bionics (BBNX) EBIT Margin (2024 - 2026)
Beta Bionics' (BBNX) quarterly EBIT Margin came in at 79.9% in Q2 2026, up 562.0% year-over-year from 12.07% in Q2 2025, and up 9.06% quarter-over-quarter from 87.86% in Q1 2026.
Analysis
Beta Bionics (BBNX) EBIT Margin (2024 - 2026) Analysis & Trends
Beta Bionics has disclosed EBIT Margin across 3 years of filings, most recently posting 79.9% for Q2 2026.
- In Q2 2026, EBIT Margin rose 562.0% year-over-year to 79.9%; the TTM figure through Jun 2026 stood at 69.75% (up 1039.0% YoY), while the FY2025 annual figure was 71.5%, down 202.0% from the prior year.
- EBIT Margin came in at 79.9% for Q2 2026 at Beta Bionics, up from 87.86% in the prior quarter.
- In the past five years, EBIT Margin ranged from a high of 50.2% in Q4 2025 to a low of 105.69% in Q1 2025.
- Average EBIT Margin over 3 years is 75.26%, with a median of 75.71% recorded in 2024.
- Year-over-year, EBIT Margin sank 3259 bps in 2025 and soared 1783 bps in 2026.
- Over 3 years, EBIT Margin stood at 63.78% in 2024, then climbed by 21 bps to 50.2% in 2025, then slumped by 59 bps to 79.9% in 2026.
- Per Business Quant data, the three most recent EBIT Margin figures were 79.9% in Q2 2026, 87.86% in Q1 2026, and 50.2% in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.55 Bn | 175.95 Bn | 7.27 Bn | 13.44% |
| 2 | Intuitive Surgical | 127.44 Bn | 122.22 Bn | 1.96 Bn | 33.60% |
| 3 | Medtronic | 117.25 Bn | 108.43 Bn | 6.34 Bn | 18.08% |
| 4 | Stryker | 105.32 Bn | 101.85 Bn | 4.50 Bn | 25.18% |
| 5 | Boston Scientific | 64.67 Bn | 64.13 Bn | 3.85 Bn | 21.65% |
| 6 | Edwards Lifesciences | 49.86 Bn | 45.61 Bn | 1.35 Bn | 29.48% |
| 7 | Alcon | 33.13 Bn | 31.67 Bn | 1.68 Bn | 0.40% |
| 8 | Dexcom | 32.24 Bn | 30.29 Bn | 830.00 Mn | 24.33% |
| 9 | Steris | 20.76 Bn | 20.28 Bn | 684.20 Mn | 19.15% |
| 10 | Beta Bionics | 754.37 Mn | 573.89 Mn | 18.90 Mn | -79.90% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -79.90% |
| Mar 31, 2026 | -87.86% |
| Dec 31, 2025 | -50.20% |
| Sep 30, 2025 | -62.54% |
| Jun 30, 2025 | -85.52% |
| Mar 31, 2025 | -105.69% |
| Dec 31, 2024 | -63.78% |
| Sep 30, 2024 | -65.71% |
| Jun 30, 2024 | -78.32% |
| Mar 31, 2024 | -73.09% |